NCT05480995

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone Positron Emission Tomography-Magnetic Resonance Imaging (PET / MRI)

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: University of North Carolina, Chapel Hill · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

Purpose: The aim of this study is to assess the sensitivity and specificity of FFNP PET/MRI for diagnosis of endometriosis. Participants: A total of 24 participants will be recruited from individuals with clinically suspected endometriosis. Procedures (methods): This is a prospective, one arm, single center study of 24 subjects with clinically suspected endometriosis to demonstrate FFNP PET-MRI's clinical utility for diagnosis of endometriosis.

Conditions

• Endometriosis

Interventions

Type	Name	Description
DRUG	18F-fluorofuranylnorprogesterone PET / MRI	Subjects will receive a PET/MRI with 18F-fluorofuranylnorprogesterone tracer

Timeline

• Start date: 2023-01-17
• Primary completion: 2026-08-01
• Completion: 2026-08-01
• First posted: 2022-07-29
• Last updated: 2026-01-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study